SEQUENT SCIENTIFIC LTD. - 512529 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting Results of Postal ballot pursuant to regulation 44 of the SEBI (Listing obligation and disclosure requirements) Regulations, 2015 and Scrutinizers Report SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Intimation of Earnings Call Transcript as per Regulation 30 of SEBI (LODR) Regulations, 2015 SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings presentation made on February 15, 2024, on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023, is available on the Company's website
Sequent Scientific Results Earnings Call for Q3FY24
Conference Call with Sequent Scientific Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript. SEQUENT SCIENTIFIC LTD. - 512529 - Announcement Under Regulation 30 (LODR)- Newspaper Publication
Newspaper publication of Financials for quarter and nine months ended 31st December 2023 SEQUENT SCIENTIFIC LTD. - 512529 - Announcement Under Regulation 30 (LODR)- Newspaper Publication
Newspaper publication of Financials for quarter and nine months ended 31st December 2023
SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for quarter ended 31st December 2023 SEQUENT SCIENTIFIC LTD. - 512529 - Board Meeting Outcome for Outcome Of Board Meeting Held On February 13, 2024, Along With Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2023.
Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2023. In thisregard, kindly find enclosed the following: 1. Unaudited Consolidated Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2023. 2. Unaudited Standalone Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2023 SEQUENT SCIENTIFIC LTD. - 512529 - Appointment of Company Secretary and Compliance Officer
Appointment of Company Secretary and Compliance Officer